Assembly Bill 555 would prohibit private insurance companies from charging people more than $35 for a 30-day supply of a ...

Japan: In January 2024, 510(K) clearance was received from the U.S. Food and Drug Administration (FDA) to market SoloSmart, Sanofi's smart medical device that connects SoloStar insulin pens was ...

Moreover, the growing preference for disposable insulin pens offers added convenience while minimizing the risk of cross-contamination. Innovations in needle technology ... a smart medical tool used ...

For example, Lantus, Sanofi's insulin glargine and one of the world's best-selling drugs, was approved as a vial in 2000 and as a pen device under the name Lantus SoloStar in 2007. This latter ...

Store KwikPens, SoloStars, Tempos, and other pens without the needle attached. The most common side effects of insulin glargine are listed below. Tell your healthcare provider if you have any of ...

The Deputy Health and Disability Commissioner has found a pharmacy breached the Code of Health and Disability Services Consumers’ Rights (the Code) for failing to dispense an insulin pen correctly. Dr ...

The breach concerns the dispensing error of the fast-release insulin pen NovoMix 30, rather than the womans usual slow-release pen Lantus Solostar. The Deputy Health ...

Insulin glargine (rDNA origin) injection. MedlinePlus. Insulin degludec (rDNA origin) injection. DailyMed. Label: Tresiba- insulin degludec injection, solution. DailyMed. Label: Lantus- insulin ...